Olga Vasiljeva

11PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersCharacterisation of biological macromoleculesMolecular targetsPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 26, 2026
Stefin B and Cystatin C Deficiency Suppresses Tumor Growth and Alters Tumor Microenvironment in a Breast Cancer Model.

Petra Matjan Štefin, Janja Završnik, Miha Butinar

|Dec 30, 2025
Structural and Proteomic Analysis of the Mouse Cathepsin B-DARPin 4m3 Complex Reveals Species-Specific Binding Determinants.

Miki Zarić, Livija Tušar, Lovro Kramer

|Oct 28, 2023
A New Cathepsin D Targeting Drug Delivery System Based on Immunoliposomes Functionalized with Lipidated Pepstatin A.

Andreja Kozak, Georgy Mikhaylov, Pavlo Khodakivskyi

|Sep 16, 2022
A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity.

Leila M Boustany, Sherry L LaPorte, Laurie Wong

|Jun 06, 2022
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate.

Shweta Singh, Laura Serwer, Amy DuPage

|Feb 15, 2022
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.

Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau

Pageof 2

Frequent Collaborators

3 joint publications

Boris Turk

3 joint publications

W Michael Kavanaugh

2 joint publications

Marjolijn N Lub-de Hooge

2 joint publications

Margaret T Nguyen